APP Pharmaceuticals Launches Rocuronium Bromide Injection (Medical News Today) PDF Print

APP Pharmaceuticals, Inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched Rocuronium Bromide Injection, the generic equivalent of Organon's Zemuron®.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.